Skip to content
healthcare.dev

Olmesartan Medoxomil

NDC 71209-080, Olmesartan Medoxomil, tablet, coated, from Cadila Pharmaceuticals Limited.

Product NDC
71209-080
Status
Listed
Labeler
Cadila Pharmaceuticals Limited
Dosage form
TABLET, COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210682
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71209-080 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OLMESARTAN MEDOXOMIL20 mg/1

Pharmacologic classes

Angiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]

Package NDCNDC-11Package
71209-080-017120900800130 TABLET, COATED in 1 BOTTLE (71209-080-01)
71209-080-047120900800490 TABLET, COATED in 1 BOTTLE (71209-080-04)
71209-080-1071209008010500 TABLET, COATED in 1 BOTTLE (71209-080-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c5416a9f-1dcc-4851-bbc0-6664d22fc8fa

Use it

Look up 71209-080 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71209-080 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71209-080. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.